Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950123-99-004739
Filing Date
1999-05-17
Accepted
1999-05-17 00:00:00
Documents
4
Period of Report
1999-03-31

Document Format Files

Seq Description Document Type Size
1 OSI PHARMACEUTICALS, INC. 10-Q 48558
2 CERTIFICATE OF INCORPORATION AS AMENDED EX-3.1 45663
3 AGREEMENT DATED MARCH 19, 1999 EX-10.1 42818
4 FINANCIAL DATA SCHEDULE EX-27 2149
  Complete submission text file 0000950123-99-004739.txt   141051
Mailing Address 106 CHARLES LINDBERGH BLVD UNIONDALE NY 11553-3649
Business Address 106 CHARLES LINDBERGH BLVD UNIONDALE NY 11553 5162220023
OSI PHARMACEUTICALS INC (Filer) CIK: 0000729922 (see all company filings)

EIN.: 133159796 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 10-Q | Act: 34 | File No.: 000-15190 | Film No.: 99624732
SIC: 2835 In Vitro & In Vivo Diagnostic Substances